- Navidea Biopharmaceuticals (NYSEMKT:NAVB) +161% on positive Tc99m tilmanocept data in rheumatoid arthritis.
- More news on: Navidea Biopharmaceuticals, Inc., Medigus Ltd., Digirad Corporation, Stocks on the move, , Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
CAE to deliver initial training for air traffic controllers and flight service specialists at the new Air Traffic Services Training Centre in Mont...
NAV CANADA and CAE form partnership to train Air Traffic Controllers and Flight Service Specialists Canada NewsWire CAE to deliver initial training for air traffic controllers and flight service specialists at the new Air Traffic Services Training Centre in Montreal . ...
CAE announces changes to its Defense & Security business leadership team CAE announces changes to its Defense & Security business leadership team Canada NewsWire MONTREAL , April 4, 2024 /CNW/ - (NYSE: CAE) (TSX: CAE) - CAE Inc. today announced changes to...